Advertisement

Pharmaceutical Research

, Volume 12, Issue 11, pp 1741–1745 | Cite as

Evaluation of the Uptake of Pravastatin by Perfused Rat Liver and Primary Cultured Rat Hepatocytes

  • Michi Ishigami
  • Taro Tokui
  • Toru Komai
  • Kosyo Tsukahara
  • Masayo Yamazaki
  • Yuichi Sugiyama
Article

Abstract

Purpose. We have already demonstrated that the HMG-CoA reductase inhibitor, pravastatin is actively taken up by isolated rat hepatocytes via a multispecific anion transporter (Yamazaki et al., Am. J. Physiol. 264, G36-44, (1993)). We further attempted the quantitative evaluation of this uptake in different experimental systems.

Methods. We have quantified the initial uptake of pravastatin by both primary cultured hepatocytes and by isolated perfused rat liver using the multiple indicator dilution (MID) method.

Results. The permeability surface area product for the influx (PSinf) of pravastatin evaluated in MID study was comparable with those reported previously in isolated rat hepatocytes and in vivo. Furthermore, the highly concentrative uptake (influx clearance >> efflux clearance) of pravastatin was confirmed by kinetic analysis of the dilution curves obtained in the MID study. On the other hand, the uptake by primary cultured cells was significantly lower than that by isolated cells, and the ability of hepatocytes to take up pravastatin showed a decrease with time in culture (0-96 hr). The Vmax for uptake diminished with increasing time in culture, while no significant change was observed in both Km and nonspecific diffusion clearance.

Conclusions. The MID method in isolated perfused liver which maintains the spatial and anatomical architecture can be used to quantitatively evaluate the initial uptake of pravastatin. Furthermore, the ability of hepatocytes to take up pravastatin is diminished in culture with time and this is caused by a decrease in Vmax.

multiple indicator dilution method primary cultured hepatocytes carrier-mediated uptake active transport HMG-CoA reductase inhibitor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    M. Yamazaki, H. Suzuki, M. Hanano, T. Tokui, T. Komai, and Y. Sugiyama. Na+-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am. J. Physiol. 264: G36–44, (1993).Google Scholar
  2. 2.
    T. Komai, E. Sigehara, T. Tokui, T. Koga, M. Ishigami, C. Kuroiwa, and S. Horiuchi. Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture. Biochem. Pharmacol. 43: 667–670, (1990).Google Scholar
  3. 3.
    S. C. Tsao, Y. Sugiyama, Y. Sawada, S. Nagase, T. Iga, and M. Hanano. Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: Analysis by multiple indicator dilution method. J. Pharmacokin. Biopharm. 14: 51–64, (1986).Google Scholar
  4. 4.
    S. Miyauchi, Y. Sugiyama, Y. Sawada, K. Morita, T. Iga, and M. Hanano. Kinetics of hepatic transport of 4-methylumbelliferone in rats: Analysis by multiple indicator dilution method. J. Pharmacokin. Biopharm. 15: 25–38, (1987).Google Scholar
  5. 5.
    H. Sato, Y. Sugiyama, Y. Sawada, T. Iga, T. Fuwa, and M. Hanano. Dynamic determination of kinetic parameters for the interaction between polypeptide hormones and cell-surface receptors in the perfused rat liver by the multiple indicator dilution method. Proc. Natl. Acad. Sci. USA 85: 8355–8359, (1988).Google Scholar
  6. 6.
    S. Miyauchi, Y. Sawada, T. Iga, M. Hanano, and Y. Sugiyama. Comparison of the hepatic uptake clearances of fifteen drugs with a wide range of membrane permeabilities in isolated rat hepatocytes and perfused rat livers. Pharm. Res. 10: 434–440, (1993).Google Scholar
  7. 7.
    C. A. Goresky, W. H. Ziegler, and G. G. Bach. Capillary exchange modeling. Circ. Res. 27: 739–764, (1970).Google Scholar
  8. 8.
    T. Kakutani, K. Yamaoka, M. Hashida, and H. Sezaki. A new method for assessment of drug disposition in muscle: Application of statistical moment theory to local perfusion system. J. Pharmacokinet. Biopharm. 13: 609–631, (1985).Google Scholar
  9. 9.
    A. W. Wolkoff, C. A. Goresky, J. Sellin, Z. Gatmaitan, I. M. Arias. Role of ligandin in transfer of bilirubin from plasma into liver. Am. J. Physiol. 236: E638–648, (1979).Google Scholar
  10. 10.
    P. Moldeus, J. Hogberg, and S. Orrenius. Isolation and use of liver cells. Methods Enzymol. 52: 60–71, (1978).Google Scholar
  11. 11.
    O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randal. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–275, (1951).PubMedGoogle Scholar
  12. 12.
    K. Yamaoka, T. Tanigawara, Y. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4: 879–885, (1981).Google Scholar
  13. 13.
    H. Nakamura, H. Sano, M. Yamazaki, and Y. Sugiyama. Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: Contribution of type I system. J. Pharmacol. Exp. Therap. 269: 1220–1227, (1994).Google Scholar
  14. 14.
    H. N. Christensen. Biological transport. W. A. Benjamin Inc, London, (1975), pp. 417–436.Google Scholar
  15. 15.
    D. S. Kelley, and V. R. Potter. Regulation of amino acid transport systems by amino acid depletion and supplementation in monolayer cultures of rat hepatocytes. J. Biol. Chem. 253: 9009–9017, (1978).Google Scholar
  16. 16.
    K. Winkler, S. Keiding, and N. Tygstrup. The liver. Quantitative aspects of structure and function. ed. by G. Paumgartner and R. Preisig. Gasel, Karger, (1973), pp. 144–155.Google Scholar
  17. 17.
    K. S. Pang, and M. Rowland. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. J. Pharmacokinet. Biopharm. 5: 625–653, (1977).Google Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • Michi Ishigami
    • 1
  • Taro Tokui
    • 1
  • Toru Komai
    • 1
  • Kosyo Tsukahara
    • 2
  • Masayo Yamazaki
    • 3
  • Yuichi Sugiyama
    • 3
  1. 1.Analytical and Metabolic Research LaboratoriesSankyo Co., Ltd.Shinagawa-ku, TokyoJapan
  2. 2.Second Department of Internal Medicine, Faculty of MedicineUniversity of TokyoBunkyo-ku, TokyoJapan
  3. 3.Faculty of Pharmaceutical SciencesUniversity of TokyoBunkyo-ku, TokyoJapan

Personalised recommendations